Clinical research in older adults with hematologic malignancies: Opportunities for alignment in the Veterans Affairs.

Management of hematologic malignancies in older patients is complex and, with recent and anticipated trends in demographics, increasingly common. As a large, nationally integrated medical system the Veterans Affairs has the potential to lead in research to benefit these patients. In this review we describe the evolving treatment paradigms of hematologic malignancies and how they are best fit with older patients through comprehensive evaluation of key vulnerabilities. We also discuss optimization of supportive care and navigation services to target identified risks and challenges aimed at ameliorating the patient's burden of cancer and treatment. Lastly, we discuss opportunities in design of prospective clinical trials to better align with real-world cases, thereby expanding enrollment of and applicability to older patients with hematologic malignancies.

[1]  M. Aljurf,et al.  Role of Physical Therapy before and after Hematopoietic Stem Cell Transplantation: White Paper Report. , 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[2]  D. Steensma.  Clinical consequences of clonal hematopoiesis of indeterminate potential. , 2018, Hematology. American Society of Hematology. Education Program.

[3]  P. Wilson,et al.  The Burden of Frailty Among U.S. Veterans and Its Association With Mortality, 2002-2012. , 2018, The journals of gerontology. Series A, Biological sciences and medical sciences.

[4]  H. Cohen,et al.  Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  B. Cheson,et al.  Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis , 2018, Haematologica.

[6]  G. Abel,et al.  Frailty and the management of hematologic malignancies. , 2018, Blood.

[7]  Aaron N. Winn,et al.  Out-of-Pocket and Health Care Spending Changes for Patients Using Orally Administered Anticancer Therapy After Adoption of State Parity Laws , 2017, JAMA oncology.

[8]  L. ZulligLeah,et al.  Cancer Incidence Among Patients of the U.S. Veterans Affairs Health Care System: 2010 Update , 2017 .

[9]  J. Byrd,et al.  Impact of ibrutinib dose adherence on therapeutic efficacy in patients with previously treated CLL/SLL. , 2017, Blood.

[10]  G. Colditz,et al.  Geriatric Assessment in Older Adults with Multiple Myeloma , 2016, Journal of the American Geriatrics Society.

[11]  M. Sorror,et al.  Comorbidities, Alcohol Use Disorder, and Age Predict Outcomes after Autologous Hematopoietic Cell Transplantation for Lymphoma. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[12]  J. Buckner,et al.  Pragmatic study designs for older adults with cancer: Report from the U13 conference. , 2016, Journal of geriatric oncology.

[13]  Traudi Rose,et al.  A Patient Navigation Model for Veterans Traveling for Cancer Care. , 2016, Federal practitioner : for the health care professionals of the VA, DoD, and PHS.

[14]  P. Lambert,et al.  Continued improvement in survival of acute myeloid leukemia patients: an application of the loss in expectation of life , 2016, Blood Cancer Journal.

[15]  K. Anderson,et al.  Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report. , 2015, Blood.

[16]  H. Wildiers,et al.  Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations†. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  N. Skoetz,et al.  Aerobic physical exercise for adult patients with haematological malignancies. , 2014, The Cochrane database of systematic reviews.

[18]  Jose M Garcia,et al.  Sarcopenia, Cachexia and Aging: Diagnosis, Mechanisms and Therapeutic Options - A Mini-Review , 2014, Gerontology.

[19]  Hayden B Bosworth,et al.  Ingredients of successful interventions to improve medication adherence. , 2013, JAMA.

[20]  T. Rector,et al.  Synchronous and metachronous malignancies: analysis of the Minneapolis Veterans Affairs (VA) tumor registry , 2013, Cancer Causes & Control.

[21]  G. Lyman,et al.  Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High‐Age Patients (CRASH) score , 2012, Cancer.

[22]  K. Scher,et al.  Under-representation of older adults in cancer registration trials: known problem, little progress. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  E. Estey,et al.  Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  J. Williamson,et al.  Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia. , 2010, Blood.

[25]  S. Grambow,et al.  Quality of nonmetastatic colorectal cancer care in the Department of Veterans Affairs. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  Benjamin D Smith,et al.  Future of cancer incidence in the United States: burdens upon an aging, changing nation. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  H. Cohen,et al.  Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). , 2005, Critical reviews in oncology/hematology.

[28]  M. Sorror,et al.  Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. , 2005, Blood.

[29]  L. Kazis,et al.  Health-related quality of life in patients served by the Department of Veterans Affairs: results from the Veterans Health Study. , 1998, Archives of internal medicine.

[30]  A. Alberg,et al.  Alcohol and Cancer: A Statement of the American Society of Clinical Oncology. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  D. Stirewalt,et al.  Hematopoietic stem cell transplantation for hematologic malignancies in older adults: geriatric principles in the transplant clinic. , 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

[32]  M. Hallek.  State-of-the-art treatment of chronic lymphocytic leukemia. , 2009, Hematology. American Society of Hematology. Education Program.